Drug intelligence / Profile preview

1-benzylimidazole

Development stage
Unknown
Modality
Small Molecules
01

Overview

**1-benzylimidazole** is a synthetic small molecule belonging to the class of N-substituted imidazoles. It is primarily used in research and as a chemical tool rather than as an approved pharmaceutical drug. The compound exhibits strong cardiotonic activity and acts as both an inducer of various cytochrome P450 (CYP) isozymes and an inhibitor of thromboxane A2 synthase. As a CYP inhibitor, it can modulate the metabolism of other compounds by affecting their biotransformation pathways. Its applications include use in biochemical studies involving enzyme inhibition and induction[2][3][4][5].

Other names
1-benzyl-1H-imidazolen-benzylimidazolebenzylimidazole1h-imidazole1-phenylmethylccris 5821ccris5821ccris-5821chembl14192chembl-14192chembl 141921bn
02

Targets

Cyp (Cyclophilin family)UGT (UDP-glucuronosyltransferase family)TBXAS1 (Thromboxane A2 synthase)

Beyond the preview

Go deeper on 1-benzylimidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-benzylimidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call